Combination of antibiotic mechanisms in lantibiotics

Farmaco

Volumn 57, Issue 8, 2002, Pages 685-691

  Hoffmann, Anja ^a   Pag, Ulrike ^a   Wiedemann, Imke ^a   Sahl, Hans Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Inhibition of cell wall biosynthesis; Lipid II; Mersacidin; Nisin; Target mediated pore formation

Indexed keywords

ACTAGARDIN; ANTIBIOTIC AGENT; EPIDERMIN; LANTIBIOTIC; LIPID; MERSACIDIN; NISIN; PEPTIDE; PEPTIDOGLYCAN; SUBTILIN; UNCLASSIFIED DRUG; VALIVARICIN A; ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BINDING AFFINITY; BIOSYNTHESIS; CHANNEL GATING; DRUG DESIGN; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SPECIFICITY; POLYMERIZATION; PRECURSOR; REVIEW; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMAL; ANTIBIOTICS, PEPTIDE; HUMAN; MOLECULAR SEQUENCE DATA; NISIN; PEPTIDOGLYCAN; ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS;

EID: 0037205949     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(02)01208-9     Document Type: Review

References (63)

1. Nonribosomal biosynthesis of peptide antibiotics
2. A nonribosomal system of peptide biosynthesis
3. Lantibiotics: Biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria
4. Lantibiotics-ribosomally synthesized biologically active polypeptides containing sulfide bridges and α,β-didehydroamino acids
5. Mode of action of the staphylococcinlike peptide Pep5: Voltage-dependent depolarization of bacterial and artificial membranes
6. Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria
7. Die Wirkung von Nisin auf Clostridium butyricum
8. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles
9. Influence of the staphylococcinlike peptide Pep5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles
10. Mode of action of the staphylococcin-like peptide Pep5 and culture conditions effecting its activity
11. r substances from the cytoplasm of sensitive cells caused by the staphylococcin-like agent Pep5
12. The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22
13. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin
14. The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes
15. Mechanism of channel-formation by lantibiotics in black lipid membranes
16. Statistical analysis of alamethicin channels in black lipid membranes
17. Electrically gated ionic channels in lipid bilayers
18. Alamethicin incorporation in lipid bilayers: A thermodynamic study
19. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers
20. Aggregation and organization of pardaxin in phospholipid membranes. A fluorescence energy transfer study
21. Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate
22. Surface location and orientation of the lantibiotic nisin bound to membrane-mimicking micelles of dodecylphophocholine and of sodium dodecylsulphate
23. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles
24. Mechanism of lantibiotic-induced pore formation
25. Solution structures of nisin and its two major degradation products determined by NMR
26. The spatial structure of nisin in aqueous solution
27. Mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity - A monolayer study
28. The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane
29. Pore formation by nisin involves translocation of its C-terminal part across the membrane
30. Interaction of nisin with planar lipid bilayers monitored by fluorescence recovery after photobleaching
31. Physicochemical characterization of the nisin-membrane interaction with liposomes derived from Listeria monocytogenes
32. Structural characterization of free and membrane-bound nisin by infrared spectroscopy
33. Interaction of the pore forming-peptide antibiotics Pep5, nisin and subtilin with non-energized liposomes
34. Structure-activity relationships in the peptide antibiotic nisin: Antibacterial activity of fragments of nisin
35. Additional antibiotic inhibitors of peptidoglycan synthesis
36. The effect of nisin on murein synthesis
37. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics
38. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic
39. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity
40. Influence of charge differences in the C-terminal part of nisin on antimicrobial activity and signaling capacity
41. Induction of autolysis of staphylococci by the basic peptide antibiotic Pep5 and nisin and their influence on the activity of autolytic enzymes
42. Autolytic system of Staphylococcus simulans 22: Influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase
43. The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms
44. Structure-activity relationships in the peptide antibiotic nisin: Role of dehydroalanine 5
45. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction
46. The lantibiotics nisin and subtilin act as extracellular regulators of their own biosynthesis
47. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides
48. Bacterial interference caused by autoinducing peptide variants
49. Gardimycin, a new antibiotic from Actinoplanes. III. Biological properties
50. Physicochemical and biological properties of actagardine and some acid hydrolysis products
51. Chemotherapeutic properties of mersacidin in vitro and in vivo
52. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin
53. Wirkung von Mersacidin auf die murine Listeriose
54. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation
55. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II
56. 13C-NMR assignments and revised primary structure
57. Stimulation of glycolysis by placental polypeptides and inhibition by duramycin
58. Effects of antibiotics and other inhibitors on ATP-dependent protein translocation into membrane vesicles
59. Interaction of duramycin with artificial and natural membranes
60. 2, and structural revision of duramycin and cinnamycin
61. 1H-NMR
62. Haemolytic activity of a cyclic peptide Ro 09-0198
63. 2